Scott Campbell

Scott Campbell is an accomplished professional in regulatory and clinical affairs with over 20 years of experience in the molecular diagnostics industry. Currently serving as Senior Vice President of Regulatory and Clinical Affairs at Cepheid since June 2010, Scott manages global teams to deliver product validations and registrations. Previous roles include Senior Vice President and General Manager of Oncology and Corporate Vice President and Chief Regulatory Officer at Cepheid, where responsibilities encompassed P&L management, strategic planning, and clinical trial execution. With a progressive career spanning several companies, including Nanosphere and Third Wave Technologies, Scott has expertise in clinical trial design, commercialization of diagnostic products, marketing, and product development. Scott holds a PhD in Cell, Molecular, and Developmental Biology, an MBA in Management, and degrees in Botany and Biology from the University of Wyoming and the University of California, Riverside.